Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018;144(8):1941–53.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.
Article PubMed PubMed Central Google Scholar
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
Article CAS PubMed Google Scholar
Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65.
Article CAS PubMed PubMed Central Google Scholar
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. JNCI J Natl Cancer Instit. 2011;103(5):368–83. https://doi.org/10.1093/jnci/djq562.
Plummer M, Schiffman M, Castle Philip E, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papilloma virus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis. 2007;195(11):1582–9.
Molano M. Determinants of clearance of human papilloma virus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003;158(5):486–94.
Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Futur Virol. 2011;6(1):45–57.
Ray K, Bala M, Bhattacharya M, Muralidhar S, Kumari M, Salhan S. Prevalence of RTI/STI agents and HIV infection in symptomatic and asymptomatic women attending peripheral health set-ups in Delhi, India. Epidemiol Inf. 2007;136(10):1432–40. https://doi.org/10.1017/S0950268807000088.
Parmar M, Solanki H, Gosalia V. A study of prevalence of Sexually Transmitted Infections & response to syndromic treatment among married women of reproductive age group in rural area of Parol primary health centre under Thane district. Glob J Med Pub Health. 2013;2(2):1–8.
Gillet E, Meys JFA, Verstraelen H, Verhelst R, De Sutter P, Temmerman M, Broeck DV. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS ONE. 2012;7(10):e45201. https://doi.org/10.1371/journal.pone.0045201.
Article CAS PubMed PubMed Central Google Scholar
Schwebke JR, Weiss HL. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis. 2002;29(1):59–64.
Caixeta RCA, Ribeiro AA, Segatti KD, Saddi VA, Figueiredo Alves RR, dos Santos Carneiro MA, et al. Association between the human papilloma virus, bacterial vaginosis and cervicitis and the detection of abnormalities in cervical smears from teenage girls and young women. Diagn Cytopathol. 2015;43(10):780–5.
National Guidelines on Prevention, Management and Control of Reproductive Tract Infections and Sexually Transmitted Infections. National AIDS Control Organisation (NACO). 2007; https://naco.gov.in/sites/default/files/STI%20RTI%20MONOGRAPH%20_NACP-III-.pdf (Accessed on 27 Dec 2024
Woodman CBJ, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7(1):11–22.
Article CAS PubMed Google Scholar
Castle PE, Giuliano AR. Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients—assessing their roles as human papillomavirus cofactors. JNCI Monogr. 2003;2003(31):29–34. https://doi.org/10.1093/oxfordjournals.jncimonographs.a003478.
Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomark Prev. 2001;10(10):1021–7.
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297–301.
Article CAS PubMed PubMed Central Google Scholar
Money D. The laboratory diagnosis of bacterial vaginosis. Can J Infect Dis Med Microbiol. 2005;16(2):77–9.
Article PubMed PubMed Central Google Scholar
Digene HC2 High-Risk HPV DNA Test. www.qiagen.com. https://www.qiagen.com/us/products/diagnostics-and-clinical-research/sexual-reproductive-health/cervical-cancer-screening/digene-hc2-high-risk-hpv-dna-test
Nayar R, Wilbur DC. The pap test and bethesda 2014. Cancer Cytopathol. 2015;123(5):271–81.
World Health Organization. Sexually transmitted infections (STIs). World Health Organization. World Health Organization: WHO. 2023. https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
HPV Prevention at a Glance [Internet]. https://hpvcentre.net/hpvatglance.php. HPV Information Centre. 2015. https://hpvcentre.net/hpvatglance.php
Yuan X, Yang Y, Gu D, Liu H, Yang H, Wang M. Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China. Arch Gynecol Obstetr. 2010;283(6):1385–9.
Liu W, Wu EQ, Yu XH, Feng LH, Jiang CL, Zha X, et al. Detection of human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in Changchun, China. Int J Gynecol Obstet. 2013;120(2):124–6.
Altuglu I, Terek MC, Ozacar T, Ozsaran AA, Bilgiç A. The prevalence of human papilloma virus DNA in women with mucopurulent endocervicitis. Eur J Gynaecol Oncol. 2002;23(2):166–8.
Anand KV, Pimple SA, Mishra GA, Sahare RV, Pathuthara S, Deodhar KK, et al. Reliability of conventional papanicolaou smear in diagnosing bacterial vaginosis among women with clinical genital infection. South Asian J Cancer. 2020;09(01):13–6.
Kim HS, Kim TJ, Lee IH, Hong SR. Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients. J Gynecol Oncol. 2016. https://doi.org/10.3802/jgo.2016.27.e49.
Article PubMed PubMed Central Google Scholar
Centers for Disease Control and Prevention. Bacterial Vaginosis—STI Treatment Guidelines. www.cdc.gov. U.S. Centers for Disease Control and Prevention. 2021. https://www.cdc.gov/std/treatment-guidelines/bv.htm
Larsen B, Monif GRG. Understanding the bacterial flora of the female genital tract. Clin Infect Dis. 2001;32(4):e69-77.
Article CAS PubMed Google Scholar
Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy vaginal microbiota and influence of probiotics across the female life span. Front Microbiol. 2022;8:13.
Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahé C, et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen. 2004;11(2):77–84.
Article CAS PubMed Google Scholar
Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer. 2003;89(1):88–93.
Comments (0)